KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $21.39 $29.07 Friday, 26th Apr 2024 ARWR stock ended at $22.12. This is 1.14% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.95% from a day low at $21.72 to a day high of $22.36.
90 days $21.39 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Mar 04, 2016 $4.33 $4.33 $4.33 $4.33 581 500
Mar 03, 2016 $4.24 $4.24 $4.24 $4.24 815 400
Mar 02, 2016 $4.43 $4.43 $4.43 $4.43 728 700
Mar 01, 2016 $4.14 $4.14 $4.14 $4.14 635 900
Feb 29, 2016 $3.90 $3.90 $3.90 $3.90 547 700
Feb 26, 2016 $3.97 $3.97 $3.97 $3.97 386 600
Feb 25, 2016 $3.86 $3.86 $3.86 $3.86 445 500
Feb 24, 2016 $3.83 $3.83 $3.83 $3.83 562 700
Feb 23, 2016 $3.88 $3.88 $3.88 $3.88 533 100
Feb 22, 2016 $4.09 $4.09 $4.09 $4.09 619 200
Feb 19, 2016 $3.94 $3.94 $3.94 $3.94 701 800
Feb 18, 2016 $3.78 $3.78 $3.78 $3.78 723 000
Feb 17, 2016 $3.94 $3.94 $3.94 $3.94 763 600
Feb 16, 2016 $3.56 $3.56 $3.56 $3.56 735 000
Feb 12, 2016 $3.36 $3.36 $3.36 $3.36 595 300
Feb 11, 2016 $3.30 $3.30 $3.30 $3.30 885 500
Feb 10, 2016 $3.21 $3.21 $3.21 $3.21 943 500
Feb 09, 2016 $3.18 $3.18 $3.18 $3.18 805 500
Feb 08, 2016 $3.24 $3.24 $3.24 $3.24 764 800
Feb 05, 2016 $3.46 $3.46 $3.46 $3.46 786 100
Feb 04, 2016 $3.69 $3.69 $3.69 $3.69 928 300
Feb 03, 2016 $3.40 $3.40 $3.40 $3.40 1 047 300
Feb 02, 2016 $3.25 $3.25 $3.25 $3.25 816 800
Feb 01, 2016 $3.45 $3.45 $3.45 $3.45 545 500
Jan 29, 2016 $3.48 $3.48 $3.48 $3.48 843 800
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT